biospecimen_aliquot__bcr_aliquot_barcode	tcga-ew-a1p0-01a-11d-a142-09
biospecimen_aliquot__bcr_aliquot_uuid	6475f4dd-782c-411a-b7ce-9c9ebd0753b8
biospecimen_aliquot__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
biospecimen_aliquot__bcr_sample_barcode	tcga-ew-a1p0-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100474770
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-04-06
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a142
biospecimen_aliquot__plate_row	b
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.91
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ew-a1p0-01a-11d
biospecimen_analyte__bcr_analyte_uuid	5cda2df8-d2ec-458d-8376-a4e59838a265
biospecimen_analyte__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
biospecimen_analyte__bcr_sample_barcode	tcga-ew-a1p0-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ew-a1p0
biospecimen_diagnostic_slides__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ew-a1p0-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	6c75eebd-ce05-4de2-8c43-8b6435f1379f
biospecimen_normal_control__bcr_patient_barcode	tcga-ew-a1p0
biospecimen_normal_control__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
biospecimen_portion__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
biospecimen_portion__bcr_portion_barcode	tcga-ew-a1p0-01a-11
biospecimen_portion__bcr_portion_uuid	d8b1628e-1dff-4f45-a28f-f4e0969f8baa
biospecimen_portion__bcr_sample_barcode	tcga-ew-a1p0-01a
biospecimen_portion__date_of_creation	2011-03-24
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ew-a1p0-01a-11d
biospecimen_protocol__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
biospecimen_protocol__bcr_sample_barcode	tcga-ew-a1p0-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
biospecimen_sample__bcr_sample_barcode	tcga-ew-a1p0-01a
biospecimen_sample__bcr_sample_uuid	f2b7091e-ed85-4546-8f11-307154153d31
biospecimen_sample__days_to_collection	1142
biospecimen_sample__initial_weight	190
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ew-a1p0.f9fb00c3-9f86-40ac-a5e8-08712cd5002b.pdf
biospecimen_sample__pathology_report_uuid	f9fb00c3-9f86-40ac-a5e8-08712cd5002b
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ew-a1p0-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	d39ecd5c-5a18-46dc-b6e6-356c239d7ec3
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17j
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ew-a1p0-01a-21-a17j-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
biospecimen_slide__bcr_sample_barcode	tcga-ew-a1p0-01a
biospecimen_slide__bcr_slide_barcode	tcga-ew-a1p0-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	01b86041-ac17-4bcf-884e-b7d48240bbe2
biospecimen_slide__image_file_name	tcga-ew-a1p0-01a-01-tsa.01b86041-ac17-4bcf-884e-b7d48240bbe2.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	15
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	35
biospecimen_slide__percent_tumor_cells	65
biospecimen_slide__percent_tumor_nuclei	75
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ew-a1p0
biospecimen_tumor_sample__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
clinical_drug__bcr_drug_barcode	tcga-ew-a1p0-d29668
clinical_drug__bcr_drug_uuid	82bb1af4-6610-45a8-bcfe-5a38d177760e
clinical_drug__bcr_patient_barcode	tcga-ew-a1p0
clinical_drug__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
clinical_drug__form_completion_date	2012-3-8
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ended_days_to	1245
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	1033
clinical_drug__prescribed_dose	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-ew-a1p0-f29105
clinical_follow_up__bcr_followup_uuid	14e24f35-f5dd-4ce1-b35a-7e14ed9bffbb
clinical_follow_up__bcr_patient_barcode	tcga-ew-a1p0
clinical_follow_up__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
clinical_follow_up__days_to_additional_surgery_metastatic_procedure	1105
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-3-8
clinical_follow_up__last_contact_days_to	1251
clinical_follow_up__new_tumor_event_dx_days_to	1094
clinical_follow_up__new_tumor_event_dx_indicator	yes
clinical_follow_up__new_tumor_event_pharmaceutical_tx	yes
clinical_follow_up__new_tumor_event_radiation_tx	no
clinical_follow_up__new_tumor_event_site	other, specify
clinical_follow_up__new_tumor_event_site_other	mediastinal lymph node
clinical_follow_up__new_tumor_event_surgery	yes
clinical_follow_up__new_tumor_event_type	distant metastasis
clinical_follow_up__nte_er_status	positive
clinical_follow_up__nte_her2_status	negative
clinical_follow_up__nte_pr_status_by_ihc	negative
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_nte__bcr_patient_barcode	tcga-ew-a1p0
clinical_nte__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
clinical_nte__nte_er_ihc_intensity_score	3+
clinical_nte__nte_er_positivity_scale_used	3 point scale
clinical_nte__nte_er_status	positive
clinical_nte__nte_er_status_ihc__positive	90-99%
clinical_nte__nte_her2_positivity_ihc_score	1+
clinical_nte__nte_her2_status	negative
clinical_nte__nte_her2_status_ihc__positive	<10%
clinical_nte__nte_pr_ihc_intensity_score	1+
clinical_nte__nte_pr_positivity_scale_used	3 point scale
clinical_nte__nte_pr_status_by_ihc	negative
clinical_nte__nte_pr_status_ihc__positive	<10%
clinical_patient__age_at_diagnosis	55
clinical_patient__ajcc_metastasis_pathologic_pm	mx
clinical_patient__ajcc_nodes_pathologic_pn	n1b
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-ew-a1p0
clinical_patient__bcr_patient_uuid	81e32f39-3aa0-468b-87ed-dd2eb6165ddf
clinical_patient__birth_days_to	-20107
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	3+
clinical_patient__er_positivity_scale_used	3 point scale
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-5-10
clinical_patient__gender	female
clinical_patient__her2_ihc_percent_positive	<10%
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	other, specify
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8523/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2008
clinical_patient__last_contact_days_to	1121
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	21
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	yes
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__nte_er_ihc_intensity_score	3+
clinical_patient__nte_er_status	positive
clinical_patient__nte_er_status_ihc__positive	90-99%
clinical_patient__nte_her2_positivity_ihc_score	1+
clinical_patient__nte_her2_status	negative
clinical_patient__nte_her2_status_ihc__positive	<10%
clinical_patient__nte_pr_ihc_intensity_score	1+
clinical_patient__nte_pr_status_by_ihc	negative
clinical_patient__nte_pr_status_ihc__positive	<10%
clinical_patient__patient_id	a1p0
clinical_patient__pr_positivity_scale_used	3 point scale
clinical_patient__pr_status_by_ihc	negative
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	ew
clinical_patient__tumor_status	with tumor
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-EW-A1P0-01A-11D-A142-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-EW-A1P0-01A-11D-A142-09.bed.meta
manually_curated__id	tcga-ew-a1p0-01a-11d-a142-09
manually_curated__md5sum	e3e6de3c595f36488eed63519aae69cf
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	6475f4dd-782c-411a-b7ce-9c9ebd0753b8
manually_curated__tumor_tag	brca
